Cite

HARVARD Citation

    de'Angelis, N. et al. (2016). Role of Sorafenib in Patients With Recurrent Hepatocellular Carcinoma After Liver Transplantation. Progress in transplantation. pp. 348-355. [Online]. 
  
Back to record